期刊文献+

人抗Aβ_(42)自身抗体的纯化及鉴定 被引量:1

Purification and identification of anti-Aβ_(42) autoantibody in healthy human serum
下载PDF
导出
摘要 目的纯化并鉴定正常人血清中抗Aβ42自身抗体。方法采集正常人血清标本,测定抗体含量,用饱和硫酸铵沉淀血清得到IgG粗品,用CNBr Sephrose 4B层析柱对粗品IgG进一步纯化,采用PAGE电泳和Western blot方法鉴定IgG纯度和免疫活性。结果用CNBr活化Sephrose 4B柱可纯化出较高纯度的抗Aβ42自身抗体,纯度可达到90%。结论 CNBr活化Sephrose 4B层析柱可有效地从人血清中纯化出较高纯度的抗Aβ42自身抗体,便于对自身抗体进一步研究,为AD的免疫治疗提供更多的信息。 Objective To purify and identify the anti- Aβ42 autoantibody in normal human serum. Methods The normal human serum was collected to determine the concentration of the antibody. The serum was precipitated with saturated ammonium sulfate to get crude serum IgG. The IgG was further isolated and purified by affinity chromatography on Aβ42 immuno-affinity column. Then PAGE and Western blot was applied to determine the purity and immune-activity of IgG. Results The Sephrose 4B affinity column activated with CNBr can produce a highly purified anti- Aβ42 autoantibody and the purity rate is high up to 90%. Conclusion The Sephrose 4B affinity column activated with CNBr can effectively produce a highly purified anti- Aβ42 autoantibody from human serum. It will facilitate further study on autoantibody and provide more information for immunization treatment of AD.
出处 《解剖学研究》 CAS 2011年第3期172-175,共4页 Anatomy Research
基金 广东省自然科学基金(73009737001284) 广东省科技计划项目(2010B031600167)
关键词 老年性痴呆 Β淀粉样蛋白 自身抗体 纯化 Alzheimer disease Amyloid-beta protein (Aβ) Autoantibody Purification
  • 相关文献

参考文献20

  • 1Geylis V, Kourilov V, Meiner Z, et al. Human monoclonal antibodies against amyloid-beta from healthy adults. Neurobiol Aging, 2005 : 26(5 ) : 597-606.
  • 2Dodel RC, Du Y, Depboylu C, et al. Intravenous immunoglobulins containing antibodies against betaamyloid for the treatment of Alzheimer's disease. J Neurol Neurosurg Psychiatry, 2004,75 (10) : 1472-1474.
  • 3Hyman BT, Smith C, Buldyrev I, et al. Autoantibodies to amyloid-beta and Alzheimer's disease. Ann Neurol, 2001,49(6) :808-810.
  • 4Relkin NR, Szabo P, Adamiak B, et al. 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease. Neurobiol Aging, 2008,2 (20) : 1-9.
  • 5李少兵,汪华侨,林贤,徐杰,姚志彬.接种Aβ_(42)全肽疫苗恒河猴的特异性体液免疫应答[J].细胞与分子免疫学杂志,2005,21(2):202-204. 被引量:6
  • 6Schenk D, Barbour R, Dunn W, et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like patholo- gy in the PDAPP mouse. Nature, 1999,400(6740) : 173- 177.
  • 7Schenk D. Amyloid-β immunotherapy for Alzheimer's disease : the end of the beginning. Nat Revi, 2002,3 : 824-828.
  • 8Bard F, Cannon C, Barbour R, et al. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med, 2000,6: 916-919.
  • 9Du Y, Dodel R, Hampel H, et al. Reduced levels of amyloid beta-peptide antibody in Alzheimer disease. Neurology, 2001, 57(5) :801-805.
  • 10Richard D, Harald H, Candan D, et al. Human antibodies against amyloid-peptide: A potential treatment for Alzheimer' s disease. Ann Neurol, 2002,52 : 251- 252.

二级参考文献33

  • 1李少兵,汪华侨,林贤,徐杰,姚志彬.接种Aβ_(42)全肽疫苗恒河猴的特异性体液免疫应答[J].细胞与分子免疫学杂志,2005,21(2):202-204. 被引量:6
  • 2Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics [ J ]. Science, 2002, 297 (5580) : 353 - 356.
  • 3Dodel RC, Du Y, Depboylu C, et al. Intravenous irmnunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease[J]. J Neurol Neurosurg Psychiatry, 2004, 75 (10): 1472 - 1474.
  • 4Xu S, Gaskin F. Increased incidence of anti-beta-amyloid autoantibodies secreted by Epstein-Barr virus transformed B cell lines from patients with Alzheimer's disease [ J ]. Mech Ageing Dev, 1997, 94 ( 1 - 3) : 213 -222.
  • 5Hyman BT, Smith C, Buldyrev I, et al. Autoantibodies to amyloid-beta and Alzheimer's disease [ J ]. Ann Neurol, 2001, 49 ( 6 ) : 808 - 810.
  • 6Relkin NR, Szabo P, Adamiak B, et al. 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease [ J ]. Neurobiology of Aging, 2008, 21 ( 1 ) : 1 -9.
  • 7Check E. Nerve inflammation halts trial for Alzheimer's drug[J]. Nature, 2002, 415(6871): 462.
  • 8Selkoe DJ. Clearing the brain' s amyloid cobwebs [ J ]. Neuron, 2001, 32(2) : 177 - 180.
  • 9Monsonego A, Maron R, Zota V, et al. Immune hyporesponsiveness to amyloid 13-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer's disease [ J]. Proc Natl Acad Sci USA, 2001,98 (18) : 10273 - 10278.
  • 10Du Y, Dodel R, Hampel H, et al. Reduced levels of amyloid β-peptide antibody in Alzheimer disease [J].Neurology, 2001,57(5) : 801-5.

共引文献14

同被引文献17

  • 1杨志勇,汪华侨,张革,林贤,谢瑶,袁群芳,姚志彬.国人外周血抗β-淀粉样蛋白抗体水平的依龄性变化[J].中山大学学报(医学科学版),2005,26(2):125-128. 被引量:8
  • 2李少兵,汪华侨,林贤,徐杰,姚志彬.接种Aβ_(42)全肽疫苗恒河猴的特异性体液免疫应答[J].细胞与分子免疫学杂志,2005,21(2):202-204. 被引量:6
  • 3Gilda Shayan,Basia Adamiak,Leila H. Choe,Norman Relkin,Kelvin H. Lee.Longitudinal effects of intravenous immunoglobulin on A lzheimer’s cerebrospinal fluid proteome[J]. ELECTROPHORESIS . 2014 (12-13)
  • 4Dennis J. Selkoe.Clearing the Brain’s Amyloid Cobwebs[J]. Neuron . 2001 (2)
  • 5Monica Di Luca,Francesca Colciaghi,Lucia Pastorino,Barbara Borroni,Alessandro Padovani,Flaminio Cattabeni.Platelets as a peripheral district where to study pathogenetic mechanisms of Alzheimer disease: the case of amyloid precursor protein[J]. European Journal of Pharmacology . 2000 (1)
  • 6Shihua Xu,Felicia Gaskin.Increased incidence of anti- β -amyloid autoantibodies secreted by Epstein-Barr virus transformed B cell lines from patients with Alzheimer’s disease[J]. Mechanisms of Ageing and Development . 1997 (1)
  • 7K. Trieb,G. Ransmayr,R. Sgonc,H. Lassmann,B. Grubeck-Loebenstein.APP peptides stimulate lymphocyte proliferation in normals, but not in patients with Alzheimer’s Disease[J]. Neurobiology of Aging . 1996 (4)
  • 8Monsonego A,Maron R,Zota V,Selkoe D J,Weiner H L.Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer’s disease. Proceedings of the National Academy of Sciences of the United States of America . 2001
  • 9McLaurin J,Cecal R,Kierstead M E,Tian X,Phinney A L,Manea M,French J E,Lambermon M H L,Darabie A A,Brown M E,Janus C,Chishti M A,Horne P,Westaway D,Fraser P E,Mount H T J,Przybylski M,St George-Hyslop P.Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4-10 and inhibit cytotoxicity and fibrillogenesis. Nature Medicine . 2002
  • 10Morgan D,Diamond D M,Gottschall P E,Ugen K E,Dickey C,Hardy J,Duff K,Jantzen P,DiCarlo G,Wilcock D,Connor K,Hatcher J,Hope C,Gordon M,Arendash G W.A beta peptide vaccination prevents memory loss in an animal model of Alzheimer’s disease. Nature . 2001

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部